{"id":1007,"date":"2018-06-14T11:28:00","date_gmt":"2018-06-14T11:28:00","guid":{"rendered":"https:\/\/pepticom.com-mando.me\/?p=1007"},"modified":"2020-06-14T11:29:32","modified_gmt":"2020-06-14T11:29:32","slug":"pepticom-is-pleased-to-announce-that-pierre-riviere-ph-d-has-joined-the-companys-scientific-advisory-board-to-advise-pepticom-on-its-peptide-therapeutics-strategy-programs-and-business","status":"publish","type":"post","link":"https:\/\/pepticom.com\/2018\/06\/14\/pepticom-is-pleased-to-announce-that-pierre-riviere-ph-d-has-joined-the-companys-scientific-advisory-board-to-advise-pepticom-on-its-peptide-therapeutics-strategy-programs-and-business\/","title":{"rendered":"Pepticom is pleased to announce that Pierre Riviere, Ph.D., has joined the company&#8217;s Scientific Advisory Board to advise Pepticom on its peptide therapeutics strategy, programs and business."},"content":{"rendered":"\n<p> Dr. Riviere has over 25 years of biopharmaceutical industry experience with R&amp;D leadership roles in target and drug discovery, nonclinical and early-stage clinical development. He is a recognized expert in peptide therapeutics with both established peptide modalities and emerging novel peptide technologies. Dr. Riviere is Founder and CEO of Peptide Logic, a San Diego-based biotech company developing novel peptide therapeutic modalities. He previously was CSO at CovX, a leading peptide-antibody conjugates company; a SVP of Pfizer worldwide R&amp;D and member of the Pfizer Leadership Team; and SVP Research at Ferring Pharmaceuticals, a leading peptide therapeutics company. He is also a co-founder of Cara Therapeutics and the Peptide Therapeutics Foundation and the Annual Peptide Therapeutics Symposium. Dr. Riviere received a Ph.D. in animal physiology and biology from the Institut National Polytechnique, Toulouse, and completed postdoctoral studies at the University of Arizona, Tucson.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Dr. Riviere has over 25 years of biopharmaceutical industry experience with R&amp;D leadership roles in target and drug discovery, nonclinical and early-stage clinical development. He is a recognized expert in peptide therapeutics with both established peptide modalities and emerging novel peptide technologies. Dr. Riviere is Founder and CEO of Peptide Logic, a San Diego-based biotech [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"acf":[],"_links":{"self":[{"href":"https:\/\/pepticom.com\/wp-json\/wp\/v2\/posts\/1007"}],"collection":[{"href":"https:\/\/pepticom.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pepticom.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pepticom.com\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pepticom.com\/wp-json\/wp\/v2\/comments?post=1007"}],"version-history":[{"count":0,"href":"https:\/\/pepticom.com\/wp-json\/wp\/v2\/posts\/1007\/revisions"}],"wp:attachment":[{"href":"https:\/\/pepticom.com\/wp-json\/wp\/v2\/media?parent=1007"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pepticom.com\/wp-json\/wp\/v2\/categories?post=1007"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pepticom.com\/wp-json\/wp\/v2\/tags?post=1007"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}